• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

MYB癌蛋白:人类癌症中新兴的参与者和潜在的治疗靶点。

MYB oncoproteins: emerging players and potential therapeutic targets in human cancer.

作者信息

Cicirò Ylenia, Sala Arturo

机构信息

Department of Life Sciences, Centre for Inflammation Research and Translational Medicine, Brunel University London, UB8 3PH, Uxbridge, UK.

出版信息

Oncogenesis. 2021 Feb 26;10(2):19. doi: 10.1038/s41389-021-00309-y.

DOI:10.1038/s41389-021-00309-y
PMID:33637673
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7910556/
Abstract

MYB transcription factors are highly conserved from plants to vertebrates, indicating that their functions embrace fundamental mechanisms in the biology of cells and organisms. In humans, the MYB gene family is composed of three members: MYB, MYBL1 and MYBL2, encoding the transcription factors MYB, MYBL1, and MYBL2 (also known as c-MYB, A-MYB, and B-MYB), respectively. A truncated version of MYB, the prototype member of the MYB family, was originally identified as the product of the retroviral oncogene v-myb, which causes leukaemia in birds. This led to the hypothesis that aberrant activation of vertebrate MYB could also cause cancer. Despite more than three decades have elapsed since the isolation of v-myb, only recently investigators were able to detect MYB genes rearrangements and mutations, smoking gun evidence of the involvement of MYB family members in human cancer. In this review, we will highlight studies linking the activity of MYB family members to human malignancies and experimental therapeutic interventions tailored for MYB-expressing cancers.

摘要

MYB转录因子从植物到脊椎动物都高度保守,这表明它们的功能涵盖了细胞和生物体生物学中的基本机制。在人类中,MYB基因家族由三个成员组成:MYB、MYBL1和MYBL2,分别编码转录因子MYB、MYBL1和MYBL2(也称为c-MYB、A-MYB和B-MYB)。MYB家族的原型成员MYB的一个截短版本最初被鉴定为逆转录病毒癌基因v-myb的产物,v-myb可导致鸟类白血病。这引发了一种假说,即脊椎动物MYB的异常激活也可能导致癌症。尽管自v-myb分离以来已经过去了三十多年,但直到最近研究人员才能够检测到MYB基因重排和突变,这是MYB家族成员参与人类癌症的确凿证据。在这篇综述中,我们将重点介绍将MYB家族成员的活性与人类恶性肿瘤联系起来的研究,以及针对表达MYB的癌症量身定制的实验性治疗干预措施。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/10b5/7910556/a4a8cd2abe45/41389_2021_309_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/10b5/7910556/a37d76f89009/41389_2021_309_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/10b5/7910556/a4a8cd2abe45/41389_2021_309_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/10b5/7910556/a37d76f89009/41389_2021_309_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/10b5/7910556/a4a8cd2abe45/41389_2021_309_Fig2_HTML.jpg

相似文献

1
MYB oncoproteins: emerging players and potential therapeutic targets in human cancer.MYB癌蛋白:人类癌症中新兴的参与者和潜在的治疗靶点。
Oncogenesis. 2021 Feb 26;10(2):19. doi: 10.1038/s41389-021-00309-y.
2
From modulation of cellular plasticity to potentiation of therapeutic resistance: new and emerging roles of MYB transcription factors in human malignancies.从细胞可塑性的调节到治疗抵抗的增强:MYB 转录因子在人类恶性肿瘤中的新出现作用。
Cancer Metastasis Rev. 2024 Mar;43(1):409-421. doi: 10.1007/s10555-023-10153-8. Epub 2023 Nov 10.
3
MYB, MYBL1, MYBL2 and NFIB gene alterations and MYC overexpression in salivary gland adenoid cystic carcinoma.涎腺腺样囊性癌中 MYB、MYBL1、MYBL2 和 NFIB 基因改变及 MYC 过表达。
Histopathology. 2017 Nov;71(5):823-834. doi: 10.1111/his.13281. Epub 2017 Aug 16.
4
Emerging role of MYB transcription factors in cancer drug resistance.MYB转录因子在癌症耐药性中的新作用。
Cancer Drug Resist. 2024 Apr 30;7:15. doi: 10.20517/cdr.2023.158. eCollection 2024.
5
Functional and structural analysis of non-synonymous single nucleotide polymorphisms (nsSNPs) in the MYB oncoproteins associated with human cancer.与人类癌症相关的 MYB 癌蛋白中非同义单核苷酸多态性(nsSNP)的功能和结构分析。
Sci Rep. 2021 Dec 17;11(1):24206. doi: 10.1038/s41598-021-03624-x.
6
Genomic analysis of diffuse pediatric low-grade gliomas identifies recurrent oncogenic truncating rearrangements in the transcription factor MYBL1.弥漫性小儿低级别胶质瘤的基因组分析鉴定出转录因子 MYBL1 中反复出现的致癌截断重排。
Proc Natl Acad Sci U S A. 2013 May 14;110(20):8188-93. doi: 10.1073/pnas.1300252110. Epub 2013 Apr 30.
7
Possible Relationship Between Alterations and Specific Primary Sites in Adenoid Cystic Carcinoma: A Clinicopathological and Molecular Study of 36 Cases.腺样囊性癌的改变与特定原发部位之间的可能关系:36例临床病理及分子研究
Yonago Acta Med. 2019 Mar 28;62(1):67-76. doi: 10.33160/yam.2019.03.010. eCollection 2019 Mar.
8
The product of the retroviral transforming gene v-myb is a truncated version of the protein encoded by the cellular oncogene c-myb.逆转录病毒转化基因v-myb的产物是细胞癌基因c-myb编码的蛋白质的截短版本。
Cell. 1983 Jun;33(2):345-55. doi: 10.1016/0092-8674(83)90416-6.
9
Adenoid Cystic Carcinoma Can Be Driven by MYB or MYBL1 Rearrangements: New Insights into MYB and Tumor Biology.腺样囊性癌可由 MYB 或 MYBL1 重排驱动:对 MYB 和肿瘤生物学的新认识。
Cancer Discov. 2016 Feb;6(2):125-7. doi: 10.1158/2159-8290.CD-15-1470.
10
Nucleotide sequence of chicken c-myb complementary DNA and implications for myb oncogene activation.鸡c-myb互补DNA的核苷酸序列及其对myb癌基因激活的意义。
Nature. 1986;319(6054):604-6. doi: 10.1038/319604a0.

引用本文的文献

1
ATOX1 Promotes Hepatocellular Carcinoma Carcinogenesis via Activation of the c-Myb/PI3K/AKT Signaling Pathway.ATOX1通过激活c-Myb/PI3K/AKT信号通路促进肝细胞癌的发生。
J Clin Transl Hepatol. 2025 Aug 28;13(8):630-643. doi: 10.14218/JCTH.2024.00422. Epub 2025 Jul 7.
2
A novel prognostic signature integrating disulfidptosis- and ferroptosis-related genes in acute myeloid leukemia.一种整合急性髓系白血病中与二硫化物诱导的细胞程序性坏死和铁死亡相关基因的新型预后标志物。
Clin Exp Med. 2025 Aug 25;25(1):303. doi: 10.1007/s10238-025-01670-7.
3
Unveiling SNX10: a key player in bladder cancer progression.

本文引用的文献

1
MYBL2 amplification in breast cancer: Molecular mechanisms and therapeutic potential.MYBL2 扩增在乳腺癌中的作用:分子机制与治疗潜力。
Biochim Biophys Acta Rev Cancer. 2020 Dec;1874(2):188407. doi: 10.1016/j.bbcan.2020.188407. Epub 2020 Aug 25.
2
Retracted: Allosteric Activators of Protein Phosphatase 2A Display Broad Antitumor Activity Mediated by Dephosphorylation of MYBL2.撤回:蛋白磷酸酶 2A 的别构激活剂通过去磷酸化 MYBL2 显示出广泛的抗肿瘤活性。
Cell. 2020 Apr 30;181(3):702-715.e20. doi: 10.1016/j.cell.2020.03.051. Epub 2020 Apr 20.
3
Upregulation of independently predicts a poorer prognosis in patients with clear cell renal cell carcinoma.
揭示SNX10:膀胱癌进展中的关键角色。
Transl Androl Urol. 2025 Jul 30;14(7):1912-1924. doi: 10.21037/tau-2025-169. Epub 2025 Jul 28.
4
Epigenome and three-dimensional genome architecture remodeling during NDM29-mediated retro-transformation of neuroblastoma cells.神经母细胞瘤细胞在NDM29介导的逆转转化过程中的表观基因组和三维基因组结构重塑
PLoS One. 2025 Jul 31;20(7):e0327466. doi: 10.1371/journal.pone.0327466. eCollection 2025.
5
Methylation aberrations and genomic instability synergistically drive the evolution of intrahepatic cholangiocarcinoma.甲基化异常与基因组不稳定性协同驱动肝内胆管癌的进展。
Epigenomics. 2025 Jul;17(10):661-674. doi: 10.1080/17501911.2025.2518919. Epub 2025 Jun 17.
6
Molecular Mechanisms of Biochanin A in AML Cells: Apoptosis Induction and Pathway-Specific Regulation in U937 and THP-1.大豆黄素在急性髓系白血病细胞中的分子机制:U937和THP-1细胞中的凋亡诱导及信号通路特异性调控
Int J Mol Sci. 2025 May 31;26(11):5317. doi: 10.3390/ijms26115317.
7
Hypoxic HPV-Positive Cancer Cells Are Particularly Sensitive to the Pro-Senescent Effects of B-MYB Repression Due to the Lack of Compensatory A-MYB Induction.由于缺乏代偿性A-MYB诱导,低氧人乳头瘤病毒阳性癌细胞对B-MYB抑制的促衰老效应尤为敏感。
J Med Virol. 2025 Jun;97(6):e70422. doi: 10.1002/jmv.70422.
8
Disruption of HaVipR1 confers Vip3Aa resistance in the moth crop pest Helicoverpa armigera.破坏棉铃虫中肠的HaVipR1可使其对Vip3Aa产生抗性,棉铃虫是一种蛾类作物害虫。
PLoS Biol. 2025 May 29;23(5):e3003165. doi: 10.1371/journal.pbio.3003165. eCollection 2025 May.
9
The Molecular Basis of Pediatric Brain Tumors: A Review with Clinical Implications.小儿脑肿瘤的分子基础:一项具有临床意义的综述
Cancers (Basel). 2025 May 4;17(9):1566. doi: 10.3390/cancers17091566.
10
Integrating Machine Learning and Bulk and Single-Cell RNA Sequencing to Decipher Diverse Cell Death Patterns for Predicting the Prognosis of Neoadjuvant Chemotherapy in Breast Cancer.整合机器学习与批量及单细胞RNA测序以解析多种细胞死亡模式用于预测乳腺癌新辅助化疗的预后
Int J Mol Sci. 2025 Apr 13;26(8):3682. doi: 10.3390/ijms26083682.
的上调独立预测透明细胞肾细胞癌患者预后较差。 (你提供的原文中“Upregulation of”后面似乎缺少具体内容)
Oncol Lett. 2020 Apr;19(4):2765-2772. doi: 10.3892/ol.2020.11408. Epub 2020 Feb 17.
4
Overexpression of MYBL2 promotes proliferation and migration of non-small-cell lung cancer via upregulating NCAPH.MYBL2 的过表达通过上调 NCAPH 促进非小细胞肺癌的增殖和迁移。
Mol Cell Biochem. 2020 May;468(1-2):185-193. doi: 10.1007/s11010-020-03721-x. Epub 2020 Mar 21.
5
Monensin, a novel potent MYB inhibitor, suppresses proliferation of acute myeloid leukemia and adenoid cystic carcinoma cells.莫能菌素,一种新型有效的 MYB 抑制剂,可抑制急性髓系白血病和腺样囊性癌细胞的增殖。
Cancer Lett. 2020 Jun 1;479:61-70. doi: 10.1016/j.canlet.2020.01.039. Epub 2020 Jan 31.
6
ATR is a MYB regulated gene and potential therapeutic target in adenoid cystic carcinoma.ATR是一种受MYB调控的基因,也是腺样囊性癌潜在的治疗靶点。
Oncogenesis. 2020 Jan 30;9(1):5. doi: 10.1038/s41389-020-0194-3.
7
miR-200 affects tamoxifen resistance in breast cancer cells through regulation of MYB.miR-200 通过调控 MYB 影响乳腺癌细胞对他莫昔芬的耐药性。
Sci Rep. 2019 Dec 11;9(1):18844. doi: 10.1038/s41598-019-54289-6.
8
Will new agents impact survival in AML?新的药物会影响 AML 的存活率吗?
Best Pract Res Clin Haematol. 2019 Dec;32(4):101094. doi: 10.1016/j.beha.2019.101094. Epub 2019 Oct 18.
9
Integrated Network Analysis Reveals FOXM1 and MYBL2 as Key Regulators of Cell Proliferation in Non-small Cell Lung Cancer.整合网络分析揭示FOXM1和MYBL2是非小细胞肺癌细胞增殖的关键调节因子。
Front Oncol. 2019 Oct 15;9:1011. doi: 10.3389/fonc.2019.01011. eCollection 2019.
10
First-in-human phase I clinical trial of a combined immune modulatory approach using TetMYB vaccine and Anti-PD-1 antibody in patients with advanced solid cancer including colorectal or adenoid cystic carcinoma: The MYPHISMO study protocol (NCT03287427).在包括结直肠癌或腺样囊性癌在内的晚期实体癌患者中使用TetMYB疫苗和抗PD-1抗体的联合免疫调节方法的首次人体I期临床试验:MYPHISMO研究方案(NCT03287427)
Contemp Clin Trials Commun. 2019 Jul 10;16:100409. doi: 10.1016/j.conctc.2019.100409. eCollection 2019 Dec.